What is the 13F Pro Quality Score for ACON?

13F Pro ranks Aclarion, Inc. (ACON) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ACON's current score at https://13fpro.ai/research/ACON (free sign-up required for the full ranking).

Where does 13F Pro source ACON data?

All Aclarion, Inc. fundamentals and ownership data come directly from SEC EDGAR. Aclarion, Inc. files with the SEC under CIK 1635077. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ACON in?

Aclarion, Inc. (ACON) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ACON research updated on 13F Pro?

ACON's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Aclarion, Inc.(ACON)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1635077 ACON stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.1M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ACON Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Aclarion, Inc. (ACON), a Healthcare sector company. ACON is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.1m in revenue. Based on the latest XBRL financial filings (Q1 2026), Aclarion, Inc. reports quarterly revenue of $21.1K, net income of $-2.9M, free cash flow of $-2.6M. Top institutional holders of ACON by reported 13-F value include OSAIC HOLDINGS,, GEODE CAPITAL MANAGEMENT,, CAPTRUST FINANCIAL ADVISORS, based on the most recent SEC filings. ACON trades on the Nasdaq exchange and files with the SEC under CIK 1635077. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Aclarion, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$21.1K

Net Income

Q1 2026

$-2.9M

Free Cash Flow

Q1 2026

$-2.6M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+65.6% YoY

$75.7KFY 2025

FY21 $60.3KFY22 $60.4KFY24 $45.7KFY25 $75.7K

Net Income

-3.4% YoY

$-7.2MFY 2025

FY21 $-5.0MFY22 $-7.1MFY24 $-7.0MFY25 $-7.2M

Operating Income

-27.9% YoY

$-7.1MFY 2025

FY21 $-3.0MFY22 $-5.6MFY24 $-5.5MFY25 $-7.1M

EPS (Diluted)

+99.8% YoY

$-4.54FY 2025

FY21 $-6.58FY22 $-1.23FY24 $-2492.97FY25 $-4.54

Total Assets

+543.9% YoY

$13.7MFY 2025

FY21 $1.9MFY22 $2.9MFY24 $2.1MFY25 $13.7M

Op. Cash Flow

-35.9% YoY

$-7.2MFY 2025

FY21 $-2.4MFY22 $-4.9MFY24 $-5.3MFY25 $-7.2M

Metric	FY 2025	FY 2024	FY 2022	FY 2021
Revenue	$75.7K +65.6%	$45.7K -24.4%	$60.4K +0.3%	$60.3K
Net Income	$-7.2M -3.4%	$-7.0M +1.1%	$-7.1M -42.8%	$-5.0M
Operating Income	$-7.1M -27.9%	$-5.5M +0.9%	$-5.6M -88.3%	$-3.0M
EPS (Diluted)	$-4.54 +99.8%	$-2492.97 -202580.2%	$-1.23 +81.3%	$-6.58
Total Assets	$13.7M +543.9%	$2.1M -27.1%	$2.9M +54.3%	$1.9M
Operating Cash Flow	$-7.2M -35.9%	$-5.3M -6.5%	$-4.9M -106.2%	$-2.4M

AI Insight: ACON Financial Trends

Aclarion remains pre-revenue with accelerating quarterly losses and no clear path to profitability.

• Net income and operating income both deteriorated to -$3M in Q1 2026, worst quarter on record.

• Operating cash flow worsened to -$3M in Q1 2026, highest cash burn in the observed period.

• Equity rose to $20M in Q1 2026 from $13M in Q4 2025, likely via capital raise to fund losses.

⚠ Zero revenue across all eight quarters indicates no commercial progress; R&D-stage company burning $10–12M annually.

⚠ Runway depends on equity raises. Equity volatility ($1M–$20M) suggests irregular financing; monitor dilution and burn rate.

AI Insight: ACON Ratio Trends

Aclarion has sustained severe profitability deterioration across all return metrics, with ROIC declining to -60.8% in Q1 2026.

• ROE worsened from -51.6% in Q1 2025 to -58.1% in Q1 2026; ROA deteriorated similarly from -49.5% to -55.3% over same period.

• ROIC collapsed from -37.8% in Q1 2025 to -60.8% in Q1 2026, marking sustained destruction of shareholder capital.

⚠ Q4 2025 marked nadir with ROE -58.9%, ROA -55.3%, ROIC -62.1%; modest stabilization in Q1 2026 warrants investigation.

⚠ No margin, leverage, or cash-flow data available; inability to diagnose root causes or assess balance-sheet stress.

Get alerted when ACON's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Aclarion, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ACON

OSAIC HOLDINGS, INC.
$114.3K34,945 sh
GEODE CAPITAL MANAGEMENT, LLC
$102.1K31,215 sh
CAPTRUST FINANCIAL ADVISORS
$47.6K14,559 sh
BANK OF MONTREAL /CAN/
$32.7K10,000 sh
UBS Group AG
$31.5K9,647 sh
VANGUARD CAPITAL MANAGEMENT LLC
$22.2K6,782 sh
Dauntless Investment Group, LLC
$17.7K5,422 sh
CAPTRUST FINANCIAL ADVISORS
$3.7K78,400 sh
Clear Street Group Inc.
$2.2K47,023 sh
Clear Street Group Inc.
$10.003 sh

Fund	Value	Shares
OSAIC HOLDINGS, INC.	$114.3K	34,945
GEODE CAPITAL MANAGEMENT, LLC	$102.1K	31,215
CAPTRUST FINANCIAL ADVISORS	$47.6K	14,559
BANK OF MONTREAL /CAN/	$32.7K	10,000
UBS Group AG	$31.5K	9,647
VANGUARD CAPITAL MANAGEMENT LLC	$22.2K	6,782
Dauntless Investment Group, LLC	$17.7K	5,422
CAPTRUST FINANCIAL ADVISORS	$3.7K	78,400
Clear Street Group Inc.	$2.2K	47,023
Clear Street Group Inc.	$10.00	3

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ACON on your watchlist

Track score changes the day Aclarion, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ACON a good stock to buy?

13F Pro's AI-powered analysis of Aclarion, Inc. (ACON) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACON are available on the ACON stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ACON?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACON. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Aclarion, Inc.'s investment landscape.